Rights and permissions
About this article
Cite this article
Switching to ezetimibe/simvastatin well worth it for CHD in Germany. Pharmacoecon. Outcomes News 489, 9 (2005). https://doi.org/10.2165/00151234-200504890-00025
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504890-00025